Skip to main content

Table 3 Models additionally adjusted for glucose metrics, PICU-stay duration and for interaction with center and randomization

From: The association of hypoglycemia with outcome of critically ill children in relation to nutritional and blood glucose control strategies

Neurodevelopmental outcome after 4 years1

Working memory

Planning and organization

Metacognition

β-Estimate (95% CI)

P

β-Estimate (95% CI)

P

β-Estimate (95% CI)

P

Model adjusted for baseline risk factors, glucose metrics and length of stay in PICU (model 1)

Hypoglycemia

1.98 (0.39 to 3.57)

0.015

1.73 (0.21 to 3.24)

0.026

1.60 (0.01 to 3.19)

0.049

After additional adjustment for baseline NSE/S100B

      

Hypoglycemia

2.13 (0.43 to 3.83)

0.014

1.87 (0.24 to 3.51)

0.025

1.74 (0.04 to 3.45)

0.045

Model 1, additionally adjusted for the interaction of hypoglycemia with center

Hypoglycemia

3.04 (0.78 to 5.31)

0.009

2.21 (0.05 to 4.38)

0.045

2.62 (0.36 to 4.88)

0.023

Hypoglycemia*center (Leuven)

− 1.49 (− 3.74 to 0.77)

0.20

− 0.68 (− 2.83 to 1.47)

0.54

− 1.42 (− 3.67 to 0.83)

0.21

After additional adjustment for baseline NSE/S100B

      

Hypoglycemia

3.99 (1.19 to 6.79)

0.005

3.19 (0.49 to 5.89)

0.021

3.61 (0.80 to 6.42)

0.012

Hypoglycemia*center (Leuven)

− 2.30 (− 5.04 to 0.45)

0.10

− 1.62 (− 4.27 to 1.02)

0.23

− 2.30 (− 5.06 to 0.45)

0.10

Model 1, additionally adjusted for the interaction of hypoglycemia with randomization

Hypoglycemia

2.06 (0.38 to 3.74)

0.016

1.90 (0.30 to 3.50)

0.020

1.82 (0.15 to 3.50)

0.033

Hypoglycemia*randomization (Late-PN)

− 0.25 (− 1.83 to 1.33)

0.75

− 0.53 (− 2.02 to 0.97)

0.49

− 0.68 (− 2.25 to 0.89)

0.40

After additional adjustment for baseline NSE/S100B

      

Hypoglycemia

2.56 (0.69 to 4.42)

0.007

2.38 (0.59 to 4.18)

0.009

2.40 (0.53 to 4.27)

0.012

Hypoglycemia*randomization (Late-PN)

− 0.97 (− 2.69 to 0.76)

0.27

− 1.14 (− 2.80 to 0.52)

0.18

− 1.47 (− 3.20 to 0.26)

0.096

  1. PICU: pediatric intensive care unit
  2. Baseline risk factors include age, sex, treatment center, randomization group, pediatric index of mortality (PIM3 score) at time of admission, Screening Tool for Risk on Nutritional Status and Growth (STRONGkids) risk level at time of admission, diagnostic category, history of malignancy, predefined syndrome, race, geographic origin, language, parental educational level, parental occupational level, parental smoking before admission, left-hand preference, and (where applicable, as indicated in the table) upon-admission concentrations of NSE and S100B. As no patient had diabetes, diabetes was not included in the multivariable models. All models were adjusted for glucose metrics in PICU (mean morning blood glucose and SD of all glucose measurements in PICU) and for length of stay in PICU
  3. 1Higher scores reflect worse performance